1059220

DermAvance Pharmaceuticals, Inc. — FEI 3005881732

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 17, 2018
Fiscal Year
2018
Product Type
Devices
Project Area
Bioresearch Monitoring
Location
Malvern, PA (United States)

Additional Details

Sponsor, Contract Research Organization

Citations

IDCFRDescription
304921 CFR 812.150(b)(5)Sponsor progress reports for significant risk study